JC Virus-Associated Progressive Multifocal Leukoencephalopathy with Transverse Myelitis Successfully Treated Using Mirtazapine
International Journal of Biomedical Research & Practice · 2023
DOI: 10.33425/2769-6294.1021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedical Research & Practice, 2023. Verfasst von Yi Tong Vincent AW und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease secondary to JC polyomavirus which rarely involves the spinal cord. Limited evidence suggest mirtazapine¬ may be effective treatment. We present a 38 year-old man on natalizumab for multiple sclerosis presenting with acute asymmetrical lower limb weakness, who was subsequently diagnosed with PML with transverse myelitis and successfully treated with mirtazapine.
Zitieren
APA
AW, Y. T. V., & Ekladious, A. (2023). JC Virus-Associated Progressive Multifocal Leukoencephalopathy with Transverse Myelitis Successfully Treated Using Mirtazapine. International Journal of Biomedical Research & Practice. https://doi.org/10.33425/2769-6294.1021
Vancouver
AW YTV, Ekladious A. JC Virus-Associated Progressive Multifocal Leukoencephalopathy with Transverse Myelitis Successfully Treated Using Mirtazapine. International Journal of Biomedical Research & Practice. 2023. doi:10.33425/2769-6294.1021
BibTeX
@article{AW2023,
author = {AW, Yi Tong Vincent and Ekladious, Adel},
title = {JC Virus-Associated Progressive Multifocal Leukoencephalopathy with Transverse Myelitis Successfully Treated Using Mirtazapine},
journal = {International Journal of Biomedical Research & Practice},
year = {2023},
doi = {10.33425/2769-6294.1021}
}
EUVIMED